New-Onset Diabetes after Renal Transplantation (NODAT): Risks & Risk Factors

Debmalya Sanyal and Kingshuk Bhattacharjee
Additional contact information
Debmalya Sanyal: Department of Endocrinology, KPC Medical College & Hospital, India
Kingshuk Bhattacharjee: JJT University, India

Current Research in Diabetes & Obesity Journal, 2019, vol. 10, issue 3, 60-61

Abstract: Renal transplantation (RT) is the last resort for patients with end-stage renal disease and is the only way out to prolong the life expectancy of such patients with an improvement in the quality of life [1]. However, the anticipated benefits of RT have to be weighed against the potential risks viz. risk of developing new onset diabetes, opportunistic infections, renal allograft rejection and transplant failure [2].

Keywords: juniper publishers; diabetes journals; diabetes impact factor; endocrinology journal; endocrinology impact factor; endocrinology research journal; endocrinology research articles; diabetes open access journals; Obesity Journal; Diabetes & Obesity Journal (search for similar items in EconPapers)
Date: 2019
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/crdoj/pdf/CRDOJ.MS.ID.555789.pdf (application/pdf)
https://juniperpublishers.com/crdoj/CRDOJ.MS.ID.555789.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jcrdoj:v:10:y:2019:i:3:p:60-61

DOI: 10.19080/CRDOJ.2019.10.555789

Access Statistics for this article

Current Research in Diabetes & Obesity Journal is currently edited by Sophia Mathis

More articles in Current Research in Diabetes & Obesity Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().